Haisco Pharmaceutical Group Co., Ltd.
002653
Rankning i aktier
#2011
Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates... Haisco Pharmaceutical Group Co., Ltd., along with its subsidiaries, operates within China, focusing on the research, production, and distribution of a diverse range of pharmaceutical products. Their offerings span various dosage forms, including small and large volume injections, freeze-dried and conventional powder injections, and active pharmaceutical ingredients (APIs). These medications target numerous therapeutic areas such as anti-infectives, digestive system disorders, blood system conditions, nervous system ailments, parenteral nutrition, antibiotics, emergency care, anesthesiology, and oncology. Furthermore, the company provides drugs in tablet, capsule, granule, and ointment forms for cardiovascular health, infectious diseases, digestive issues, central nervous system (CNS) conditions, diabetes, and hepatic diseases. Established in 2000 and based in Shannan, China, the company adopted its current name, Haisco Pharmaceutical Group Co., Ltd., in March 2016, having previously been known as Xizang Haisco Pharmaceutical Group Co., Ltd.
Aktiekurs
$9.03
Marknadsvärde
$10.30B
Förändring (1 dag)
4.55%
Förändring (1 år)
24.15%
Land
CN
Handel Haisco Pharmaceutical Group Co., Ltd. (002653)
Kategori
Healthcare
P/S-tal för Haisco Pharmaceutical Group Co., Ltd. (002653)
P/S-tal per October 2026 TTM: 11.39
Enligt Haisco Pharmaceutical Group Co., Ltd. senaste finansiella rapporter och aktiekurs är det aktuella P/S-talet (TTM) 11.39. I slutet av 2023 hade företaget ett P/S-tal på 7.85.
Historik för P/S-tal för Haisco Pharmaceutical Group Co., Ltd. från 2008 till 2026
P/S-tal vid årets slut
| År | P/S-tal | Ändra |
|---|---|---|
| 2026 (TTM) | 11.39 | 13.83% |
| 2024 | 10.01 | 27.45% |
| 2023 | 7.85 | -1.08% |
| 2022 | 7.94 | 0.22% |
| 2021 | 7.92 | 40.72% |
| 2020 | 5.63 | 1.76% |
| 2019 | 5.53 | 55.83% |
| 2018 | 3.55 | -42.00% |
| 2017 | 6.12 | -47.45% |
| 2016 | 11.65 | -39.34% |
| 2015 | 19.20 | 26.40% |
| 2014 | 15.19 | -29.52% |
| 2013 | 21.55 | 56.97% |
| 2012 | 13.73 | 21.62% |
| 2011 | 11.29 | -1.72% |
| 2010 | 11.49 | -13.31% |
| 2009 | 13.25 | -25.65% |
| 2008 | 17.82 | 0.00% |
P/S-tal för liknande företag eller konkurrenter
| Företag | P/S-tal | Skillnad i P/S-tal | Land |
|---|---|---|---|
| 10.02 | -12.04% |
US
|
|
| 40.55 | 255.89% |
US
|
|
| 3.96 | -65.24% |
AU
|
|
| 10.15 | -10.95% |
NL
|
|
| - | - |
CH
|
